Medtronic AT500 Brady/AT Stimulator Begins 260-Patient U.S. Trials
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's AT500 cardiac stimulator's first human implant marks the beginning of U.S. clinical trials for the device, following FDA approval of an investigational device exemption application in October.